Floatz logo

FDOPA

Adult Anaplastic Ependymoma

Erik MittraSmall moleculeEarly Phase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Adult Anaplastic Ependymoma cohort.

Asset / SponsorPhaseRating
Cediranib
City of Hope Medical Center
Phase 1CCC
Bafetinib
City of Hope Medical Center
Phase 1CC
Alisertib
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase 1CC
rg4733
National Cancer Institute (NCI)
Phase 1CC
EF-5
National Cancer Institute (NCI)
Phase 1C
Etanidazole
National Cancer Institute (NCI)
N/AD
Gadobutrol
University of Southern California
N/AD
GADOBENATE DIMEGLUMINE
University of Southern California
N/AD

Same molecule, other indications

FDOPA is also rated in:

congenital isolated hyperinsulinismDormant
BB
Indicative ·
66 / 100
View asset →
brain gliomaDormant
B
Indicative ·
63 / 100
View asset →
Lewy body dementiaDormant
B
Indicative ·
63 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →